Asset Dedication’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Asset Dedication's VRTX Position: Q3 2026 in Review
Asset Dedication held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 237 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #370.
Asset Dedication first reported a position in VRTX in Q4 2015 and has held it in 18 quarters since. The position peaked at $133K in Q4 2025. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Asset Dedication held 237 shares of Vertex Pharmaceuticals worth $124K as of Q3 2026.
- Asset Dedication left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
- Vertex Pharmaceuticals made up 0.01% of Asset Dedication's portfolio in Q3 2026, its #370 holding.
- Asset Dedication first reported a position in Vertex Pharmaceuticals in Q4 2015 and has held it in 18 quarters since.
- Asset Dedication's Vertex Pharmaceuticals position peaked at $133K in Q4 2025.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.